NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING OF ACTIVE BIOTECH AB (PUBL)
March 13 2019 - 1:15PM
The shareholders of Active Biotech AB (publ) are invited to the
Extraordinary Shareholders' Meeting to be held on Thursday April 4,
2019, at 5.00 pm in the Company's offices, Scheelevägen 22 in Lund,
Sweden.
ENTITLEMENT TO
PARTICIPATE
Shareholders who wish to participate in the Meeting must (i) be
recorded in the register of shareholders maintained by Euroclear
Sweden AB on Friday March 29, 2019, and (ii) notify the Company of
their intention to participate in the Meeting not later than on
Friday March 29, 2019.
Shareholders who have trustee-registered their shares must
re-register the shares in their own name to be entitled to
participate in the Meeting. Such registration, which may be
temporary, must be completed on Friday March 29, 2019. Accordingly,
shareholders must inform the trustee of this request in ample time
prior to this date.
There are a total of 145,236,480 shares and votes in Active Biotech
AB. The Company holds no treasury shares.
NOTICE OF
PARTICIPATION
Notice of participation in the Meeting can be made in writing to
Active Biotech AB (publ), Attn: Susanne Jönsson, P.O. Box 724,
SE-220 07 Lund, Sweden, by telephone +46 (0)46-19 20 00 or by
e-mail to susanne.jonsson@activebiotech.com. The notice shall
include name, personal/corporate identity number, number of shares
held, daytime telephone number and, if applicable, the number of
advisors (not more than two) that will accompany the shareholder at
the Meeting.
Shareholders represented by proxy shall issue in writing a dated
and signed power of attorney for the proxy. If the power of
attorney is issued on behalf of a legal entity, a certified copy of
a registration certificate or corresponding document that indicates
the authorized signatory shall be appended. The original power of
attorney and, where applicable, the registration certificate should
be submitted to the Company at the address indicated above well in
advance of the Meeting. Proxy forms are provided at the Company's
website, www.activebiotech.com, and sent to shareholders that so
request.
PROPOSED AGENDA
-
Opening of the Meeting
-
Election of Chairman of the Meeting
-
Preparation and approval of the voting
list
-
Election of one or two persons to
verify the minutes
-
Approval of the agenda of the
Meeting
-
Determination of whether the Meeting
has been duly convened
-
The Board of Director's proposal to approve sale
of property
-
Closing of the Meeting
PROPOSED RESOLUTION
Resolution to approve sale of property (item
7)
Active Biotech has on March 13, 2019, entered into an agreement
regarding the sale of the Company's property Forskaren 1 in Lund,
Sweden, with a newly formed investor collective led by the real
estate company Estea AB.
The purchase price amounts to SEK
275 million. Active Biotech's largest shareholder, MGA Holding AB,
has, on the request of Estea, declared its willingness to
participate with up to 40 percent of Estea's equity financing.
Hence, the sale is conditional upon the approval of the
shareholders of Active Biotech.
The Board of Directors proposes
that the Meeting resolves to approve the sale.
Resolution in accordance with the
Board of Directors' proposal requires support by more than half of
the votes cast at the Meeting. MBA Holding AB's votes shall thereby
not be considered.
________________________
DOCUMENTATION, ETC.
Shareholders are reminded of their right to request information
under Chapter 7, Section 32 of the Swedish Companies Act. The Board
of Directors' complete proposal for resolution and statement
pursuant to item 7 on the agenda, along with an independent
fairness opinion, will be held available at the Company's premises,
Scheelevägen 22 in Lund, Sweden, and at www.activebiotech.com, not
later than three weeks prior to the Meeting, and will be sent to
shareholders that so request. For information about the processing
of your personal data, please refer to
https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf.
Active Biotech's corporate
registration number is 556223-9227 and its registered office is in
Lund, Sweden.
Lund, March 2019
Active Biotech AB (publ)
The Board of Directors
NOTICE OF EGM OF ACTIVE BIOTECH AB
(PUBL)
This
announcement is distributed by West Corporation on behalf of West
Corporation clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Active Biotech via Globenewswire
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Sep 2023 to Sep 2024